Jijón Andrade, María Clara http://orcid.org/0000-0002-9858-7369
Pujol Muncunill, Gemma http://orcid.org/0000-0002-9660-5826
Lozano Ruf, Ana http://orcid.org/0000-0002-6553-3110
Álvarez Carnero, Laura http://orcid.org/0000-0001-6531-7912
Vila Miravet, Victor http://orcid.org/0000-0002-4934-6411
García Arenas, Dolores http://orcid.org/0000-0001-7487-0250
Egea Castillo, Natalia http://orcid.org/0000-0001-5585-102X
Martín de Carpi, Javier http://orcid.org/0000-0002-3631-9625
Article History
Received: 30 March 2023
Accepted: 16 June 2023
First Online: 29 June 2023
Declarations
:
: The study was approved by the local ethics committee of Hospital Sant Joan de Deu (Ref No. PIC-42-23). Due to the retrospective nature of the study, the need for written informed consent was waived by the local ethics committee of Hospital Sant Joan de Deu (Ref No. PIC-42-23). All experiments were performed in accordance with relevant guidelines and regulations such as the Declaration of Helsinki.
: Not applicable.
: MCJA received honoraria from the Nestlé Institute of Health Sciences for developing this manuscript. She received support from the Nestlé Institute of Health Sciences to attend the 6th International Symposium on PIBD. GPM received honoraria for lectures, presentations, educational events or support for attending meetings or travel from Abbvie, Nestlé Institute of Health Sciences, Nutricia, Pfizer and Janssen. ALR received support from Nestlé Health Science, Lactalis, and Mead Johnson for attending meetings. JMD received consultation fees from Abbvie and Adacyte. He received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Nestlé Health Science, Abbvie, and Adacyte. He received support for attending meetings and/or travel Nestlé Health Science, Abbvie, Adacyte, Pfizer, FAES, and Jansen. He received payments for participation in on a Data Safety Monitoring Board or Advisory Board from Abbvie. The remaining authors have no competing interests to declare.